[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"enteral-feeding\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:enteral-feeding":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,75,100],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100530635","positive-feeding-of-the-preterm-infant-100530635",false,"NCT06189352","Positive Feeding of the Preterm Infant","Positive Feeding of the Preterm Infant - a Feasibility Study of a Developmental Supportive Feeding Strategy in the NICU","PoP","Inclusion Criteria:\n\n* gestational age of 28 weeks\n* post menstrual age of 28 weeks after transition from regional hospital\n\nExclusion Criteria:\n\n* diagnoses or malformations that makes eating difficult\n* triplets or more\n* parents not speaking\u002Funderstanding Norwegian or English\n* parents with challenges or special needs for follow up",true,"ALL",{"count":20,"type":21},15,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this feasibility study is to assess the feasibility to implement a feeding strategy for preterm infants.\n\nThe main questions it aims to answer are:\n\n* Is it feasible to implement the PoP-intervention in a level 3a category Neonatal intensive care unit?\n* Is the PoP-intervention acceptable for parents of preterm infants and health care personnel working in Neonatal intensive care unit?\n\nParents of preterm infants and health care personnel will be asked to follow a protocol of a feeding strategy based on the preterm infants development and cues throughout the NICU-stay.",[27,28,29,30,31,32],"Preterm Infant","Breast Feeding","Bottle Feeding","Enteral Feeding","Cue Based Feeding","Develomentally Supportive Care","RECRUITING","2025-08-05",{"date":36,"type":37},"2025-08-11","ACTUAL",{"date":39,"type":37},"2024-10-14",{"date":41,"type":21},"2026-05",{"name":43,"class":44},"Oslo Metropolitan University","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":17,"sex":18,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":45},"100476647","tactilekinesthetic-stimulus-program-100476647","NCT05486663","Tactile\u002Fkinesthetic Stimulus Program","The Effect of the Tactile\u002Fkinesthetic Stimulus Program on the Maturation of Sucking Ability in Preterm Infants","Inclusion criteria\n\n* Born between 28-32 weeks of gestation,\n* Stable vital signs,\n* 1st and 5th minute APGAR score between 6-10,\n* Babies who have received mechanical ventilator or continuous positive air pressure (CPAP) or both support after 48 hours have passed after stabilization,\n* Does not have an anomaly that will prevent feeding,\n* Oral feeding decision has been made,\n* Babies of mothers who are willing to breastfeed their babies,\n* Babies of parents who volunteered to participate in the study will be taken.\n\nExclusion criteria\n\n* IUGG,\n* Infants with severe asphyxia,\n* Babies born with low birth weight according to their gestational week,\n* Having an anomaly that will prevent her from feeding,\n* Babies with unstable vital signs,\n* Babies with congenital anomalies or serious complications\n* Infants with intraventricular bleeding.\n\nDismissal Criteria\n\n• Babies whose oral feeding process is interrupted for more than 1 day due to neonatal problems.","28 Weeks","32 Weeks",{"count":56,"type":21},80,[24],"The study will be carried out as a prospective randomized controlled clinical study to determine the effect of tactile\u002Fkinesthetic stimulus program on preterm infants on transition time to full sucking, sucking success and hospital stay.",[60,30,61],"Breast Feeding, Exclusive","Hospital Stay",[63,64,65],"breasfeeding","enteral feeding","tactile\u002Fkinesthetic intervention","2024-11-20",{"date":68,"type":37},"2024-11-22",{"date":70,"type":37},"2022-08-01",{"date":72,"type":21},"2025-08-01",{"name":74,"class":44},"Gonca Karatas Baran",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":17,"sex":18,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":85,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":45},"100521671","enteral-feeding-of-premature-babies-and-olive-oil-supplementation-100521671","NCT06072625","Enteral Feeding of Premature Babies and Olive Oil Supplementation","The Effect of Enteral Organic Extra Virgin Olive Oil Supplementation in Premature Babies on Postnatal Growth and Premature Morbidities","Inclusion Criteria:\n\n* Premature babies born at 32 weeks or less\n* Babies who tolerate full enteral feeding at the before end of the second week\n* Babies given consent by their parents -\n\nExclusion Criteria:\n\n* Having a congenital or genetic anomaly","14 Days","40 Days",{"count":56,"type":21},[24],"It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml\u002Fkg\u002Fday of the study product (ULTRA PREMIUM) after full enteral feeding.\n\nSupplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values.\n\nDaily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.",[88,89,30],"Premature","Olive Oil","2024-07-12",{"date":92,"type":37},"2024-07-15",{"date":94,"type":37},"2023-10-01",{"date":96,"type":21},"2025-03-31",{"name":98,"class":99},"Bursa City Hospital","OTHER_GOV",{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":106,"eligibilityCriteria":107,"healthyVolunteers":11,"sex":18,"minAge":108,"maxAge":4,"enrollmentInfo":109,"targetDuration":4,"studyType":22,"phases":111,"briefSummary":112,"conditions":113,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":45},"100447891","the-effects-of-pancreatic-enzyme-supplementation-in-critically-ill-patients-on-enteral-feeding-100447891","NCT05112328","The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding","The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial","PREZENT","Inclusion Criteria:\n\n* Adults 19 years and older\n* Hospitalized in the surgical\u002Fmedical intensive care unit of the Seoul National University Hospital\n* Enteral nutrition\n* Patients who consented to this study\n* Patients with risk factors for pancreatic exocrine dysfunction\n\n  * Shock (Norepinephrine)\n  * Sepsis (3 rd definition of sepsis)\n  * Diabetes\n  * Cardiac arrest\n  * hyperlactatemia serum lactate \\> 2 mmol\u002FL)\n  * Mechanical ventilation\n  * Continuous renal replacement therapy\n\nExclusion Criteria:\n\n* chronic pancreatitis\n* unresectable pancreatic cancer\n* History of pancreatectomy\n* Underlying diseases in which the effect of Exocrine pancreatic enzyme administration is difficult to show\n\n  * Inflammatory bowel disease\n  * Short bowel syndrome","18 Years",{"count":110,"type":21},170,[24],"Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.",[114,30,115],"Critically Ill","Exocrine Pancreatic Insufficiency","2021-11-04",{"date":118,"type":37},"2021-11-08",{"date":120,"type":37},"2021-07-07",{"date":122,"type":21},"2026-07-31",{"name":124,"class":44},"Seoul National University Hospital"]